Makoto Inoue

Medicine & Life Sciences

1. Neuralgia 100%
2. Substance P 96%
3. Autoimmune Experimental Encephalomyelitis 91%
4. lysophosphatidic acid 86%
5. Nociception 84%
6. nociceptin 81%
7. Morphine 77%
8. Lysophosphatidic Acid Receptors 75%
9. Inflammasomes 63%
10. Nociceptors 62%
11. Capsaicin 57%
12. kyotorphin 55%
13. nociceptin receptor 51%
14. Bradykinin 49%
15. Analgesia 49%
16. Multiple Sclerosis 45%
17. Pain Measurement 45%
18. Hyperalgesia 42%
19. T-Lymphocytes 41%
20. Osteopontin 38%
21. Pain 37%
22. 3-(2-methoxybenzylamino)-2-phenylpiperidine 36%
23. Nerve Endings 36%
24. Opioid Analgesics 35%
25. Spinal Cord 35%
26. Wounds and Injuries 33%
27. Morphine Dependence 32%
28. Peripheral Tolerance 31%
29. Analgesics 31%
30. Injections 28%
31. N-Methyl-D-Aspartate Receptors 28%
32. 4-hydroxymercuribenzoate 27%
33. Interferons 27%
34. phosphoramidon 27%
35. Enkephalins 26%
36. Tachykinin Receptors 25%
37. Opioid Receptors 24%
38. Oligodeoxyribonucleotides 24%
39. Dynorphins 23%
40. Sciatic Nerve 22%
41. Unmyelinated Nerve Fibers 22%
42. Immune Reconstitution Inflammatory Syndrome 21%
43. Myelinated Nerve Fibers 21%
44. Peripheral Nerves 21%
45. Pertussis Toxin 21%
46. Neurons 21%
47. Astrocytes 20%
48. Cryptococcus 20%
49. TRPV1 receptor 20%
50. Spinal Injections 19%